Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000167.xml
Int J Angiol 1996; 5(4): 192-195
DOI: 10.1007/BF02044256
DOI: 10.1007/BF02044256
Original Articles
© Georg Thieme Verlag KG Stuttgart · New York
Is the captopril test suitable as a screening test for renovascular hypertension in a general hypertensive population?
Presented at the 36th Annual World Congress, International College of Angiology, New York, New York, July 1994Further Information
Publication History
Publication Date:
22 April 2011 (online)

Abstract
The goal of this study was to determine whether the captopril test is suitable as a screening tool for renovascular hypertension (RVH) in the primary care setting. Of the 100 consecutive patients with definite hypertension included in this prospective study, three (3%) were found to have RVH. The captopril test detected RVH with a 100% sensitivity, a 90% specificity, and a 23% positive predictive value by using the three combined criteria developed by the investigators at Cornell University. We conclude that the captopril test is a worthwhile screening test for RVH in an unselected, but well prepared, general hypertensive population with normal renal function.